MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-25-2026
Edwards Lifesciences Corporation Cash Conversion Cycle 2011-2026 | EW
Annual Cash Conversion Cycle Edwards Lifesciences Corporation
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 283 | 309 | 311 | 352 | 203 | 224 | 201 | 236 | 232 | 188 | 214 | 190 | 241 | 219 | 201 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 352 | 188 | 240 |
Quarterly Cash Conversion Cycle Edwards Lifesciences Corporation
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 299 | 295 | 318 | - | 358 | 357 | 327 | - | 351 | 322 | 237 | - | 130 | 118 | 208 | - | 221 | 209 | 232 | 39.4 | 238 | 283 | 226 | 42.2 | 192 | 189 | 232 | 41.1 | 235 | 216 | 221 | 45.1 | 236 | 236 | 197 | 48.7 | 189 | 185 | 193 | 44.5 | 222 | 210 | 222 | 45.1 | 178 | 196 | 211 | 53.6 | 263 | 286 | 254 | 57.8 | 297 | 262 | 230 | 70.8 | 264 | 254 | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 358 | 39.4 | 205 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M |  USA |
 |
Abbott Laboratories
ABT
|
101 | $ 104.93 | 0.34 % | $ 183 B | USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
-81.2 | - | 1.37 % | $ 20.5 M | USA |
 |
Align Technology
ALGN
|
137 | $ 167.25 | -5.68 % | $ 12.5 B | USA |
 |
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
Accuray Incorporated
ARAY
|
184 | $ 0.4 | 6.74 % | $ 41.1 M | USA |
 |
Alphatec Holdings
ATEC
|
240 | $ 11.08 | -3.82 % | $ 1.66 B | USA |
 |
Conformis
CFMS
|
165 | - | - | $ 16.4 M | USA |
 |
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
-29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
Bruker Corporation
BRKR
|
227 | $ 34.41 | -2.65 % | $ 5.13 K | USA |
 |
Boston Scientific Corporation
BSX
|
107 | $ 69.2 | -1.38 % | $ 102 B | USA |
 |
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
ClearPoint Neuro
CLPT
|
217 | $ 9.17 | -2.34 % | $ 260 M | USA |
 |
CONMED Corporation
CNMD
|
212 | $ 35.66 | -2.67 % | $ 1.11 B | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
853 | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
81.2 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Electromed
ELMD
|
180 | $ 24.33 | -0.51 % | $ 206 M | USA |
 |
Cytosorbents Corporation
CTSO
|
50.6 | $ 0.59 | -1.62 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
-61.8 | $ 2.21 | -2.64 % | $ 3.45 M | USA |
 |
Establishment Labs Holdings
ESTA
|
339 | $ 56.38 | -5.9 % | $ 1.67 B |  Costa-rica |
 |
PAVmed
PAVM
|
-111 | $ 8.75 | -2.13 % | $ 63.3 M | USA |
 |
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | USA |
 |
FONAR Corporation
FONR
|
234 | $ 18.54 | -0.03 % | $ 122 M | USA |
 |
InspireMD
NSPR
|
176 | $ 1.65 | -4.75 % | $ 106 M | Israel |
 |
Helius Medical Technologies
HSDT
|
18.2 | $ 1.92 | -4.48 % | $ 1.17 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
222 | $ 9.36 | -0.21 % | $ 721 M | USA |
 |
Inogen
INGN
|
48.9 | $ 6.3 | -3.08 % | $ 168 M | USA |
 |
AdaptHealth Corp.
AHCO
|
20.1 | $ 11.2 | -1.84 % | $ 1.51 B | USA |
 |
IRIDEX Corporation
IRIX
|
119 | $ 0.97 | -28.0 % | $ 15.6 M | USA |
 |
IRadimed Corporation
IRMD
|
224 | $ 97.63 | -1.12 % | $ 1.24 B | USA |
 |
Penumbra
PEN
|
352 | $ 335.13 | -0.38 % | $ 13 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
714 | $ 15.74 | -3.73 % | $ 369 M | USA |
 |
LivaNova PLC
LIVN
|
113 | $ 61.48 | -3.41 % | $ 3.35 B |  Britain |
 |
LENSAR
LNSR
|
147 | $ 5.59 | 1.27 % | $ 64.4 M | USA |